Present at Seed Showcase
For seed companies, this is an incredible opportunity to showcase your innovation in the Seed Showcase Track and attend Biotech Showcase — all for one all-inclusive, discounted rate!
Up to 50 seed-stage companies will be chosen to give a 7-minute company presentation to investors, biopharma companies, and tech transfer offices.
2025 – Seed Showcase Sponsors
Priority review deadlines
Apply early and receive priority review and presentation slot placements.
Round 1 | August 1, 2025
Round 2 | August 15, 2025
Round 3 | August 29, 2025
Round 4 | September 12, 2025
Round 5 | September 26, 2025
Round 6 | October 10, 2025
Round 7 | October 24, 2025
Round 8 | November 7, 2025
Round 9 | November 21, 2025
Round 10 | December 5, 2025
Round 11 | December 19, 2025
Round 12 | January 2, 2026
Benefits of presenting
- UNMATCHED VALUE: A dedicated 7-minute in-person presentation in San Francisco, putting your company in front of key investors and industry leaders and full registration to attend Biotech Showcase sessions and network with top-tier attendees.
- ACCESS THE RIGHT AUDIENCE: Biotech Showcase and its family of events attract investors representing over USD 400 Billion in capital, and highly motivated strategic partners in the life science ecosystem. 36% of attendees are investors - don't miss your chance to stand in front of the right audience.
- MORE ONE-TO-ONE MEETINGS: Based on previous events, presenting biotech companies have 15% more meetings than other attending biotech companies.
Pricing & Application Criteria
Please Note: Before registering, company presenters must apply for approval. Approved applicants will receive special instructions to complete registration.
For additional details on the cancellation policy, payment terms, or sending a replacement attendee, please click here
Pricing for Presentation:
- $1,625 - before August 15, 2025
- $1,925 - before September 26, 2025
- $2,225 - before November 7, 2025
- $2,525 - after November 8, 2025
Presentation Package Includes:
- One registration for the presenter
- A 7-minute in-person presentation in San Francisco
- Access to request meetings with investors and attendees via partneringONE® software
Criteria
To be eligible, companies must meet the following requirements:
- A seed-stage company with total financing of USD 2 million or less (this includes dilutive and non-dilutive funding and grants)
- Created in the last three years
- Employing fewer than five people
- Developing new therapeutic products, technology platforms, digital medicine, or medtech technologies
Enhanced support for presenting companies
MARKETING: We continue to enhance our marketing efforts for presenting companies. Activities include:
- Promotional emails and posts on all media channels leading up to the conference.
- Distribution of presenting company list to pharma and investors to support organizing meetings.
MEDIA: We offer a variety of opportunities to share the latest news. Activities include:
Embargoed News: Companies with key announcements are encouraged to share embargoed news or press releases with our media team ahead of distribution. Send your press release or a summary to ensure it reaches media outlets and attending press during the event. All embargo dates will be strictly honored.
Press Release Distribution: Press releases from presenting companies will be shared across our social media channels, reaching our network of investors, pharma executives, and biotech leaders.
Press Release Templates: A template announcing your selection as a presenter, including presentation date and time, will be provided for your use. [View press release templates here]
PRESENTER GUIDELINES: The presenter guidelines include tips and tricks on how to perfect your presentation as well as important dates and the length of your presentation.
Questions?
Send all of your presenting company questions to our team at PresenterInfo@demy-colton.com